What the TGA’s recent opioid changes mean for GPs Adjunct Professor John Skerritt of the Therapeutic Goods Administration outlines why the regulator is making changes to opioid indications and pack sizes.
High-risk sports supplements to be regulated as medicines The TGA will regulate supplements formulated to look like medicines with therapeutic claims from 30 November.
Questions regarding over-the-counter CBD products in pharmacies Australia’s first authorised GP prescriber of medicinal cannabis says making it easier for doctors to prescribe would be a safer way to increase access.
Shortage of diabetes medicine raises larger questions There are concerns over a TGA notice that allows pharmacists to substitute metformin XR 500 mg without consulting the prescriber.
Is it time to consider self-testing for respiratory illness? At-home diagnostic medical devices have been floated as a potential way to ease the strain on public health, but experts say concerns remain.
Medicinal cannabis clinic and dispensary to open in Melbourne But one expert has raised a number of ethical concerns.
Anti-vaxxer’s actions prompt TGA statement A recent incident saw an anti-vaccination advocate enter a general practice under false pretences to remove National Immunisation Program posters.
Life after mesh: One patient’s harrowing experience with transvaginal mesh Justine Watson lost her career, her family, her home and nearly her life after she received a pelvic mesh implant, but she hopes GPs and their patients can benefit from her story.
Opioid marketing scrutinised by TGA, questioned by RACGP The Therapeutic Goods Administration has confirmed it is examining opioid marketing material aimed at GPs.
TGA releases improved patient information Updates to the Consumer Medicines Information are aimed at improving patient understanding and safety of medicine use.